Galaxy Surfactants reported a strong Q1 FY27, with net profit surging 108.7% to Rs 165.9 crore and revenue rising 38.5% to Rs 1,785.2 crore. Motilal Oswal has reiterated a 'Buy' rating with a price target of Rs 3,160, driven by US market success and premium product sales. Investors should monitor the sustainability of current high margins as management guides for normalization in the coming quarters.
Galaxy Surfactants (GALSURF) has delivered a strong performance in the first quarter of fiscal year 2027, with the company's net profit more than doubling to Rs 165.9 crore, a 108.7% jump compared to the same period last year. Revenue for the quarter rose 38.5% to Rs 1,785.2 crore. This growth was largely supported by the company's US specialty business, which saw exceptional demand, and a recovery in sales volumes within the Indian market.
A key driver of this profitability was the company's operational efficiency, with EBITDA per kilogram surging 77% to approximately Rs 35,458. This spike in operational profit has led analysts at Motilal Oswal to maintain a bullish outlook on the stock. The brokerage has reiterated its 'Buy' rating and set a price target of Rs 3,160. Motilal Oswal anticipates healthy growth for the company over the FY26-28 period, driven by momentum in premium specialty products and an upward revision in earnings estimates.
While the Q1 results were strong, investors should pay attention to the guidance regarding margins. The company experienced unusually high profitability in the first quarter, with EBITDA per metric ton reaching levels that management expects to normalize in future quarters. While the company raised its FY27 EBITDA guidance to a range of Rs 24,000 to Rs 25,000 per ton, experts expect this figure to potentially stabilize around Rs 21,000 to Rs 22,000 per ton as market conditions balance out. This suggests that while growth remains a key theme, the explosive margin expansion seen in the first quarter may not be a permanent baseline.
Additionally, the company faces external risks that could impact future volumes. Challenges such as geopolitical disruptions in the Africa, Middle East, and Turkey (AMET) region and potential volatility in feedstock prices remain important monitorables. These factors can create supply chain and volume fluctuations, which are typical risks for specialty chemical manufacturers.
As of August 18, 2026, the stock was trading around Rs 2,397, following a 52-week high of Rs 2,659.35 recorded on August 17, 2026. Moving forward, shareholders will likely track the company's ability to maintain its premium product momentum and whether demand in key geographies like the US and India remains steady enough to support the higher EBITDA guidance provided by the management.